Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David M. Lucas is active.

Publication


Featured researches published by David M. Lucas.


Archive | 2014

response to therapy distinct molecular characteristics and does not indicate a suboptimal Prolonged lymphocytosis during ibrutinib therapy is associated with

Danelle F. James; Fong Clow; Gerard Lozanski; Amy J. Johnson; John C. Byrd; Rose Mantel; Jeffrey A. Jones; Joseph M. Flynn; Kami Maddocks; Susan O'Brien; Richard R. Furman; David M. Lucas; Katie Williams; Weiqiang Zhao; Laura Z. Rassenti; Emanuela M. Ghia; Thomas J. Kipps; Jennifer A. Woyach; Kelly A. Smucker; Lisa L. Smith; Arletta Lozanski; Yiming Zhong; Amy S. Ruppert


Archive | 2013

in chronic lymphocytic leukemia Selective inhibitors of nuclear export show that CRM1/XPO1 is a target

Dilara McCauley; Sharon Shacham; Michael Kauffman; John C. Byrd; Amy J. Johnson; David M. Lucas; Dirk Daelemans; Vincent Sandanayaka; Sharon Shechter; Emilia Mahoney; Caroline Berglund; Sneha V. Gupta; Alicia Farmer; Rajeswaran Mani; Rosa Lapalombella; Qingxiang Sun; Katie Williams; Larissa Tangeman; Shruti Jha; Yiming Zhong


Archive | 2013

high-risk chronic lymphocytic leukemia associated with marked clinical efficacy in refractory, genetically Flavopiridol administered using a pharmacologically derived schedule is

A. Dimitrios Colevas; Michael R. Grever; David M. Lucas; Nyla A. Heerema; Gerard Lozanski; Donn C. Young; Jose-Ramon Suarez; Kristie A. Blum; Brad H. Rovin; Michelle Brooker-McEldowney; Sarah Broering; Larry J. Schaaf; Amy J. John; C. Byrd; Thomas S. Lin; James T. Dalton; Mitch A. Phelps; Beth Fischer; Mollie E. Moran


Archive | 2013

cyclophosphamide, and rituximab lymphocytic leukemia patients treated with pentostatin, Mcl-1 expression predicts progression-free survival in chronic

David M. Lucas; Clive S. Zent; Timothy G. Call; Nyla A. Heerema; Gerard Lozanski; John C. Byrd; F. Jelinek; Renee C. Tschumper; Charla Secreto; Thomas S. Lin; Michael R. Grever; T. Awan; Neil E. Kay; Melanie E. Davis; Wenting Wu; Susan Geyer; Nelson Leung


Archive | 2013

development tool for human chronic lymphocytic leukemia Characterization of the TCL-1 transgenic mouse as a preclinical drug

Carlo M. Croce; Michael R. Grever; John C. Byrd; Amy J. Johnson; David M. Lucas; Natarajan Muthusamy; Lisa L. Smith; Ryan B. Edwards


Archive | 2013

intracellular calcium leukemia cells with impaired oxygen consumption and mobilization of Flavopiridol causes early mitochondrial damage in chronic lymphocytic

Michael R. Grever; Serge Viatchenko-Karpinski; Amy S. Ruppert; John C. Byrd; Periannan Kuppusamy; A. Hussain; David M. Lucas; Amy J. Johnson; Thomas S. Lin; Alan P. Bakaletz


Archive | 2013

with p53 mutations and deletions Alemtuzumab is an effective therapy for chronic lymphocytic leukemia

Michael R. Grever; John C. Byrd; Mollie E. Moran; Margaret S. Lucas; Thomas S. Lin; Marcy L. Hackbarth; John Proffitt; David M. Lucas; Gerard Lozanski; Nyla A. Heerema; Ian W. Flinn; Lisa L. Smith; Jennifer Harbison; Jennifer Webb


Archive | 2012

protein tyrosine phosphatase PTPROt in leukemia AP-1 elements and TCL1 protein regulate expression of the gene encoding

Xiaokui Mo; David Jarjoura; John C. Byrd; Carlo M. Croce; Samson T. Jacob; Mohamed Kaou; Yiming Zhong; Amy J. Johnson; David M. Lucas; Nyla A. Heerema; John P. Hagan; Tasneem Motiwala; Nicola Zanesi; Jharna Datta; Huban Kutay; Allyn M. Checovich


Archive | 2010

apoptosis induction B-cell chronic lymphocytic leukemia: evidence of caspase activation and The mechanism of tumor cell clearance by rituximab in vivo in patients with

John C. Byrd; Shinichi Kitada; Ian W. Flinn; Jennifer L. Aron; Michael Pearson; David M. Lucas; Carrie E. John


Archive | 2010

chronic lymphocytic leukemia and acute myeloid leukemia A phase 1 and pharmacodynamic study of depsipeptide (FK228) in

S. Tejaswi; Philip F. Binkley; John J. Wright; Kenneth K. Chan; Michael R. Grever Roshini; Thomas S. Lin; Shujun Liu; Amy R. Sklenar; Melanie E. Davis; David M. Lucas; Elizabeth A. Fischer; John C. Byrd; Guido Marcucci; Mark R. Parthun; Jim J. Xiao; Rebecca B. Klisovic; Mollie E. Moran

Collaboration


Dive into the David M. Lucas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amy J. Johnson

The Ohio State University Wexner Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge